Program Information

Main Meeting Program

6 PLENARY SESSIONS:

  • Cardiovascular Cell Therapy
  • Pluripotency: Embryonic and iPS
  • Stem Cells for Gene Therapy
  • Regenerative Medicine and Positioning for Commercial Success
  • Immunotherapy and T Cell
  • Presidential Plenary on Mesenchymal Stem Cells

TECHNICAL SESSIONS
WORKSHOPS
STRATEGIES FOR COMMERCIALIZATION TRACK
TRACK TECHNICAL APPLICATIONS TRACK
ORAL ABSTRACT PRESENTATIONS AND POSTER SESSIONS
CORPORATE SYMPOSIA AND TUTORIALS

Pre-Conference Workshops (June 5, 2012)

GLOBAL REGULATORY PERSPECTIVES PRE-CONFERENCE WORKSHOP

Topics include

  • Global Regulatory Updates
  • Product Approval
  • Compliance
  • Cord Blood

CELLULAR THERAPY INSPECTION AND ACCREDITATION PRE-CONFERENCE WORKSHOP ORGANIZED BY FACT






Confirmed Plenary Speakers & Chairs:

Eduardo Bravo, MBA
TiGenix, Belgium
Nathalie Cartier, MD
INSERM, France
Massimo Dominici, MD
University of Modena, Italy
Mark Frohlich, MD
Dendreon Corporation, USA
Jacques Galipeau, MD
Emory University, USA
Kurt Gunter, MD
Hospira Inc., USA
Edwin Horwitz, MD, PhD
The Children's Hospital of Philadelphia, USA
Hans-Peter Kiem, MD, FACP
FHCRC, University of Washington School of Medicine, USA
Christoph Klein, MD, PhD
Hannover Medical School, Germany
Michael Laflamme, MD, PhD
Center for Cardiovascular Biology, University of Washington, USA
Tracey Lodie, PhD
Genzyme, USA
John McMannis, PhD
Mesoblast, USA
Andras Nagy, PhD
Mount Sinai Hospital, Canada
Darwin Prockop, MD, PhD
Texas A&M Health Science Center
Shahin Rafii, MD
Weill Cornell Medical College, USA
John Rasko, MBBS, PhD
RPA Hospital, Australia
Andrew Scharenberg, MD
Immunology, University of Washington, USA